Sequence Properties of An Intramolecular Interaction That Inhibits p53 DNA Binding
- PMID: 36358908
- PMCID: PMC9687289
- DOI: 10.3390/biom12111558
Sequence Properties of An Intramolecular Interaction That Inhibits p53 DNA Binding
Abstract
An intramolecular interaction between the p53 transactivation and DNA binding domains inhibits DNA binding. To study this autoinhibition, we used a fragment of p53, referred to as ND WT, containing the N-terminal transactivation domains (TAD1 and TAD2), a proline rich region (PRR), and the DNA binding domain (DBD). We mutated acidic, nonpolar, and aromatic amino acids in TAD2 to disrupt the interaction with DBD and measured the effects on DNA binding affinity at different ionic strengths using fluorescence anisotropy. We observed a large increase in DNA binding affinity for the mutants consistent with reduced autoinhibition. The ΔΔG between DBD and ND WT for binding a consensus DNA sequence is -3.0 kcal/mol at physiological ionic strength. ΔΔG increased to -1.03 kcal/mol when acidic residues in TAD2 were changed to alanine (ND DE) and to -1.13 kcal/mol when all the nonpolar residues, including W53/F54, were changed to alanine (ND NP). These results indicate there is some cooperation between acidic, nonpolar, and aromatic residues from TAD2 to inhibit DNA binding. The dependence of DNA binding affinity on ionic strength was used to predict excess counterion release for binding both consensus and scrambled DNA sequences, which was smaller for ND WT and ND NP with consensus DNA and smaller for scrambled DNA overall. Using size exclusion chromatography, we show that the ND mutants have similar Stokes radii to ND WT suggesting the mutants disrupt autoinhibition without changing the global structure.
Keywords: DNA binding; counterion condensation theory; fluorescence anisotropy; hydrodynamic radius; intramolecular interaction; intrinsically disordered proteins; salt-dependent binding affinity; tumor suppressor p53; van’t Hoff.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
Figures





































Similar articles
-
Interaction between p53 N terminus and core domain regulates specific and nonspecific DNA binding.Proc Natl Acad Sci U S A. 2019 Apr 30;116(18):8859-8868. doi: 10.1073/pnas.1903077116. Epub 2019 Apr 15. Proc Natl Acad Sci U S A. 2019. PMID: 30988205 Free PMC article.
-
A phosphorylation-dependent switch in the disordered p53 transactivation domain regulates DNA binding.Proc Natl Acad Sci U S A. 2021 Jan 5;118(1):e2021456118. doi: 10.1073/pnas.2021456118. Epub 2020 Dec 21. Proc Natl Acad Sci U S A. 2021. PMID: 33443163 Free PMC article.
-
Extended string binding mode of the phosphorylated transactivation domain of tumor suppressor p53.J Am Chem Soc. 2014 Oct 8;136(40):14143-52. doi: 10.1021/ja506351f. Epub 2014 Sep 29. J Am Chem Soc. 2014. PMID: 25216154
-
Interaction between the transactivation domain of p53 and PC4 exemplifies acidic activation domains as single-stranded DNA mimics.J Biol Chem. 2009 Aug 7;284(32):21728-37. doi: 10.1074/jbc.M109.006429. Epub 2009 Jun 12. J Biol Chem. 2009. PMID: 19525231 Free PMC article.
-
The Transactivation Domains of the p53 Protein.Cold Spring Harb Perspect Med. 2017 Jan 3;7(1):a026047. doi: 10.1101/cshperspect.a026047. Cold Spring Harb Perspect Med. 2017. PMID: 27864306 Free PMC article. Review.
Cited by
-
Commonly asked questions about transcriptional activation domains.Curr Opin Struct Biol. 2024 Feb;84:102732. doi: 10.1016/j.sbi.2023.102732. Epub 2023 Dec 5. Curr Opin Struct Biol. 2024. PMID: 38056064 Free PMC article. Review.
-
Targeting tumor suppressor p53 for organ fibrosis therapy.Cell Death Dis. 2024 May 14;15(5):336. doi: 10.1038/s41419-024-06702-w. Cell Death Dis. 2024. PMID: 38744865 Free PMC article. Review.
-
Protein disorder and autoinhibition: The role of multivalency and effective concentration.Curr Opin Struct Biol. 2023 Dec;83:102705. doi: 10.1016/j.sbi.2023.102705. Epub 2023 Sep 29. Curr Opin Struct Biol. 2023. PMID: 37778184 Free PMC article. Review.
-
How does p53 work? Regulation by the intrinsically disordered domains.Trends Biochem Sci. 2025 Jan;50(1):9-17. doi: 10.1016/j.tibs.2024.10.009. Epub 2024 Nov 21. Trends Biochem Sci. 2025. PMID: 39578215 Review.
-
Targeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studies.MedComm (2020). 2023 May 28;4(3):e288. doi: 10.1002/mco2.288. eCollection 2023 Jun. MedComm (2020). 2023. PMID: 37256211 Free PMC article. Review.
References
-
- Tishler R.B., Calderwood S.K., Coleman C.N., Price B.D. Increases in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents. Cancer Res. 1993;53((Suppl. 10)):2212–2216. - PubMed
-
- Hainaut P., Hollstein M. p53 and human cancer: The first ten thousand mutations. Adv. Cancer Res. 2000;77:81–137. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous